Specifically, IFF encapsulated NovaSOL Curcumin and NovaSOL Curcumin/Boswellia from Aquanova AG.
IFF (New York City) has announced that it successfully encapsulated high viscosity liquid and semi-liquid nutritional ingredients into a plant-based non-gelatin soft-shell capsule using its patented SeaGel technology. Specifically, IFF encapsulated NovaSOL Curcumin and NovaSOL Curcumin/Boswellia from Aquanova AG, a German-based B2B manufacturer of liquid colloidal formulations. IFF calls this an industry-first technical breakthrough.
“The importance of SeaGel cannot be understated when supporting the delivery of ingredients of such high viscosity such as liquid curcumin,” said Benjamin Roscoe, application development and innovation manager at IFF, in a press release. “We are thrilled with this new breakthrough in one of the most technically challenging aspects in plant-based softgels.”
SeaGel capsules offer film strength, elasticity, and performance that matches animal-derived gelatin. “More and more consumers are replacing their intake of animal-based products with plant-based alternatives and we have been searching for solutions to meet this demand,” said Frank Behnam, CEO of Aquanova AG. “Our proprietary NovaSOL technology significantly enhances the efficacy and application scope of natural ingredients. The ability to encapsulate NovaSOL in a vegan softgel using SeaGel is a significant milestone and we are very excited about this achievement.”